Suppr超能文献

限时进食对非肥胖健康志愿者的随机对照试验。

Randomized controlled trial for time-restricted eating in healthy volunteers without obesity.

机构信息

Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, PUMC & Chinese Academy of Medical Sciences, Beijing, China.

Peking Union Medical College (PUMC), PUMC & Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Nat Commun. 2022 Feb 22;13(1):1003. doi: 10.1038/s41467-022-28662-5.

Abstract

Time-restricted feeding (TRF) improves metabolic health. Both early TRF (eTRF, food intake restricted to the early part of the day) and mid-day TRF (mTRF, food intake restricted to the middle of the day) have been shown to have metabolic benefits. However, the two regimens have yet to be thoroughly compared. We conducted a five-week randomized trial to compare the effects of the two TRF regimens in healthy individuals without obesity (ChiCTR2000029797). The trial has completed. Ninety participants were randomized to eTRF (n=30), mTRF (n=30), or control groups (n=30) using a computer-based random-number generator. Eighty-two participants completed the entire five-week trial and were analyzed (28 in eTRF, 26 in mTRF, 28 in control groups). The primary outcome was the change in insulin resistance. Researchers who assessed the outcomes were blinded to group assignment, but participants and care givers were not. Here we show that eTRF was more effective than mTRF at improving insulin sensitivity. Furthermore, eTRF, but not mTRF, improved fasting glucose, reduced total body mass and adiposity, ameliorated inflammation, and increased gut microbial diversity. No serious adverse events were reported during the trial. In conclusion, eTRF showed greater benefits for insulin resistance and related metabolic parameters compared with mTRF. Clinical Trial Registration URL: http://www.chictr.org.cn/showproj.aspx?proj=49406 .

摘要

限时进食(TRF)可改善代谢健康。早期限时进食(eTRF,将进食时间限制在一天的早期)和午间限时进食(mTRF,将进食时间限制在一天的中午)都已显示出具有代谢益处。然而,这两种方案尚未进行彻底比较。我们进行了一项为期五周的随机试验,以比较两种 TRF 方案在没有肥胖的健康个体中的效果(ChiCTR2000029797)。该试验已完成。90 名参与者使用基于计算机的随机数生成器随机分为 eTRF(n=30)、mTRF(n=30)或对照组(n=30)。82 名参与者完成了整个五周的试验并进行了分析(eTRF 组 28 人,mTRF 组 26 人,对照组 28 人)。主要结果是胰岛素抵抗的变化。评估结果的研究人员对分组分配不知情,但参与者和护理人员知情。在这里,我们表明 eTRF 在改善胰岛素敏感性方面比 mTRF 更有效。此外,eTRF 而非 mTRF 可改善空腹血糖,减少全身质量和肥胖,改善炎症,并增加肠道微生物多样性。在试验过程中未报告严重不良事件。总之,与 mTRF 相比,eTRF 对胰岛素抵抗和相关代谢参数显示出更大的益处。临床试验注册网址:http://www.chictr.org.cn/showproj.aspx?proj=49406

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0a7/8864028/4f7a7fa94c3c/41467_2022_28662_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验